Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect ofERCC1polymorphisms
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect ofERCC1polymorphisms
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 12, Issue 10, Pages 1417-1427
Publisher
Future Medicine Ltd
Online
2011-09-09
DOI
10.2217/pgs.11.93
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SNPs inERCC1and drug response to cisplatin in non-small-cell lung cancer patients
- (2011) Kayo Osawa PHARMACOGENOMICS
- Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
- (2010) Giuliano Ciarimboli et al. AMERICAN JOURNAL OF PATHOLOGY
- Relation Between Renal Dysfunction Requiring Renal Replacement Therapy and Promoter Polymorphism of the Erythropoietin Gene in Cardiac Surgery
- (2010) Aron F. Popov et al. ARTIFICIAL ORGANS
- Influence of Oct1/Oct2-Deficiency on Cisplatin-Induced Changes in Urinary N-Acetyl- -D-Glucosaminidase
- (2010) R. M. Franke et al. CLINICAL CANCER RESEARCH
- Prediction of Fluoroquinolone-Induced Elevation in Serum Creatinine Levels: A Case of Drug–Endogenous Substance Interaction Involving the Inhibition of Renal Secretion
- (2010) Y Imamura et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- ERCC1, toxicity and quality of life in advanced NSCLC patients randomized in a large multicentre phase III trial
- (2010) Adam Vilmar et al. EUROPEAN JOURNAL OF CANCER
- New Clues for Nephrotoxicity Induced by Ifosfamide: Preferential Renal Uptake via the Human Organic Cation Transporter 2
- (2010) Giuliano Ciarimboli et al. MOLECULAR PHARMACEUTICS
- New loci associated with kidney function and chronic kidney disease
- (2010) Anna Köttgen et al. NATURE GENETICS
- Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studies
- (2010) Mladen Vassilev Tzvetkov et al. PHARMACOGENOMICS
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
- (2009) K K Filipski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
- (2009) M V Tzvetkov et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gastrosplenic Fistula From Hodgkin's Lymphoma
- (2009) Carolyn D. Seib et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-associated renal dysfunction
- (2009) Vaibhav Sahni et al. Nature Reviews Nephrology
- Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes
- (2009) Penelope A. Bradbury et al. Pharmacogenetics and Genomics
- Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
- (2009) A V Khrunin et al. PHARMACOGENOMICS JOURNAL
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD
- (2008) Lesley A. Stevens et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
- (2008) L Paré et al. BRITISH JOURNAL OF CANCER
- A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients
- (2008) A. Woelfelschneider et al. CARCINOGENESIS
- Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients
- (2008) Katja Ott et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Relationship BetweenERCC1Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin and Paclitaxel for Stage III Epithelial Ovarian Cancer
- (2008) Thomas C. Krivak et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
- Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)
- (2008) Oliver Zolk et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis
- (2008) Sunita J. Shukla et al. Pharmacogenetics and Genomics
- Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
- (2008) Z. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer
- (2008) Zhao-Hui Huang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started